|
|
Post by hopetoretire on Oct 1, 2017 16:05:49 GMT -5
MannKind Corporation to Hold Investor Conference Call
Scheduled for Monday, October 2, 2017 at 9 AM ET
WESTLAKE VILLAGE, Calif., Oct. 01, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) and (TASE:MNKD) will host a conference call on Monday, October 2, 2017 to discuss Company developments at 9:00 AM (Eastern Time).
Presenting from the Company will be its Chief Executive Officer, Michael Castagna and Chief Financial Officer, Steven Binder.
|
|
|
|
Post by oncostat on Oct 1, 2017 16:08:20 GMT -5
|
|
|
|
Post by sportsrancho on Oct 1, 2017 16:09:16 GMT -5
ShareThis Print E-mail Email this page MannKind Corporation to Hold Investor Conference Call Scheduled for Monday, October 2, 2017 at 9 AM ET WESTLAKE VILLAGE, Calif., Oct. 01, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) and (TASE:MNKD) will host a conference call on Monday, October 2, 2017 to discuss Company developments at 9:00 AM (Eastern Time). Presenting from the Company will be its Chief Executive Officer, Michael Castagna and Chief Financial Officer, Steven Binder. To participate in the live call by telephone, please dial (888) 771-4371 or (847) 585-4405 and use the participant passcode: 45747145. Those interested in listening to the conference call live via the Internet may do so by visiting the Company's website at www.mannkindcorp.com under News & Events. A telephone replay of the call will be accessible for approximately 14 days following completion of the call by dialing (888) 843-7419 or (630) 652-3042 and use the participant passcode: 4574 7145#. A replay will also be available on MannKind's website for 14 days. About MannKind Corporation MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. MannKind is currently commercializing Afrezza® (insulin human) inhalation powder, the Company's first FDA approved product, in the United States, where it is available by prescription from pharmacies nationwide. MannKind is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, Connecticut. The Company also employs field sales and medical representatives across the U.S. For further information, visit www.mannkindcorp.com. Company Contact: Rose Alinaya SVP, Investor Relations 818.661.5000 ir@mannkindcorp.com |
|
|
|
Post by johnhindepost on Oct 1, 2017 16:12:40 GMT -5
I got my MannKind Email Alert........... it's very handy.
|
|
|
|
Post by celo on Oct 1, 2017 16:18:12 GMT -5
Well well well
|
|
|
|
Post by babaoriley on Oct 1, 2017 16:21:03 GMT -5
Sorry, oncostat, but given what has gone on on this board all weekend, I gotta wonder whether this is fake or not.  The thing that really throws me, is that Sla wasn't the one to break the story! Hoping for 100% good news! |
|
|
|
Post by kimi on Oct 1, 2017 16:21:29 GMT -5
not often glad to live in germany. But tomorrow morning I'll be.
Interesting that not only MC will hold the CC. What is the new CFO going to tell us?
|
|
|
|
Post by babaoriley on Oct 1, 2017 16:25:21 GMT -5
not often glad to live in germany. But tomorrow morning I'll be. Interesting that not only MC will hold the CC. What is the new CFO going to tell us? Yes, indeed, good news/not so good news? That's why I'm hoping for 100% good news. The financing of our existence could be a bit of a downer - well, something to ponder till 6am Pacific Time. There easily could be other things to reveal, most of which would be good. |
|
|
|
Post by brewguy on Oct 1, 2017 16:26:40 GMT -5
CEO and CFO on the call. I predict a duel announcement regarding label change plus dilution notice for recapitalization. This will mitigate damage from dilution notice.
|
|
|
|
Post by careful2invest on Oct 1, 2017 16:29:01 GMT -5
Sorry, oncostat, but given what has gone on on this board all weekend, I gotta wonder whether this is fake or not. The thing that really throws me, is that Sla wasn't the one to break the story! Hoping for 100% good news! Not sure if you were being facetious or not, but from what I read on this mb this weekend, even what was posted on twitter and stocktwits, I was expecting this announcement. I even said that "we will probably hear something from mnkd pre market!" We longs have waited a very long time for this turnaround! But better late than never! GO MNKD! THE SKY IS THE LIMIT! |
|
|
|
Post by babaoriley on Oct 1, 2017 16:33:39 GMT -5
Sorry, oncostat, but given what has gone on on this board all weekend, I gotta wonder whether this is fake or not. The thing that really throws me, is that Sla wasn't the one to break the story! Hoping for 100% good news! Not sure if you were being facetious or not, but from what I read on this mb this weekend, even what was posted on twitter and stocktwits, I was expecting this announcement. I even said that "we will probably hear something from mnkd pre market!" We longs have waited a very long time for this turnaround! But better late than never! GO MNKD! THE SKY IS THE LIMIT! careful2invest, with me, if you pick facetious, you'd be right 80% of the time; and when you see a , it gets really close to 100%. |
|
|
|
Post by churchmouse on Oct 1, 2017 16:36:23 GMT -5
We've learned how to deal with disappointment, now let's learn how to handle success.
|
|
|
|
Post by peppy on Oct 1, 2017 16:37:38 GMT -5
ShareThis Print E-mail Email this page MannKind Corporation to Hold Investor Conference Call Scheduled for Monday, October 2, 2017 at 9 AM ET WESTLAKE VILLAGE, Calif., Oct. 01, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) and (TASE:MNKD) will host a conference call on Monday, October 2, 2017 to discuss Company developments at 9:00 AM (Eastern Time). Presenting from the Company will be its Chief Executive Officer, Michael Castagna and Chief Financial Officer, Steven Binder. To participate in the live call by telephone, please dial (888) 771-4371 or (847) 585-4405 and use the participant passcode: 45747145. Those interested in listening to the conference call live via the Internet may do so by visiting the Company's website at www.mannkindcorp.com under News & Events. A telephone replay of the call will be accessible for approximately 14 days following completion of the call by dialing (888) 843-7419 or (630) 652-3042 and use the participant passcode: 4574 7145#. A replay will also be available on MannKind's website for 14 days. About MannKind Corporation MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. MannKind is currently commercializing Afrezza® (insulin human) inhalation powder, the Company's first FDA approved product, in the United States, where it is available by prescription from pharmacies nationwide. MannKind is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, Connecticut. The Company also employs field sales and medical representatives across the U.S. For further information, visit www.mannkindcorp.com. Company Contact: Rose Alinaya SVP, Investor Relations 818.661.5000 ir@mannkindcorp.com The conference call is prior to the open. oh, weehaw. We know Afrezza is a fine insulin. Because we have eyeballs.
|
|
|
|
Post by boytroy88 on Oct 1, 2017 16:43:28 GMT -5
ShareThis Print E-mail Email this page MannKind Corporation to Hold Investor Conference Call Scheduled for Monday, October 2, 2017 at 9 AM ET WESTLAKE VILLAGE, Calif., Oct. 01, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) and (TASE:MNKD) will host a conference call on Monday, October 2, 2017 to discuss Company developments at 9:00 AM (Eastern Time). Presenting from the Company will be its Chief Executive Officer, Michael Castagna and Chief Financial Officer, Steven Binder. To participate in the live call by telephone, please dial (888) 771-4371 or (847) 585-4405 and use the participant passcode: 45747145. Those interested in listening to the conference call live via the Internet may do so by visiting the Company's website at www.mannkindcorp.com under News & Events. A telephone replay of the call will be accessible for approximately 14 days following completion of the call by dialing (888) 843-7419 or (630) 652-3042 and use the participant passcode: 4574 7145#. A replay will also be available on MannKind's website for 14 days. About MannKind Corporation MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. MannKind is currently commercializing Afrezza® (insulin human) inhalation powder, the Company's first FDA approved product, in the United States, where it is available by prescription from pharmacies nationwide. MannKind is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, Connecticut. The Company also employs field sales and medical representatives across the U.S. For further information, visit www.mannkindcorp.com. Company Contact: Rose Alinaya SVP, Investor Relations 818.661.5000 ir@mannkindcorp.com The conference call is prior to the open. oh, weehaw. We know Afrezza is a fine insulin. Because we have eyeballs.
And from what most have said if news break on Monday morning before market opens it's usually good news....but then....MNKD has "learned" me to tame my expectations...but I'm almost always optimistic when it comes to MNKD....just hoping that this time I'm not disappointed.  GLTA! |
|
|
|
Post by peppy on Oct 1, 2017 16:49:53 GMT -5
hopetoretire, you are the fastest. Thank you.
Ragtime Cowboy Joe www.youtube.com/watch?v=lIzN5LrhQHA "How they run when they hear the feller's gun
Because the western folks all know:
He's a hifalootin' scootin', shootin'
Son-of-a-gun from Arizona
Ragtime cowboy (talk about your cowboy)
Ragtime cowboy… "
Dont Stop Me Now Lyrics www.youtube.com/watch?v=IFUjwj_RB5o I'm a shooting star leaping through the skies
Like a tiger defying the laws of gravity
I'm a racing car passing by like Lady Godiva
I'm gonna go go go
There's no stopping me
|
|
GLTA!